CKM and cardiomyopathy: Puccio and coworkers in 2001 [22] developed the MCK-Cre cardiac mouse model expressing the Cre recombinase under the muscle creatine kinase (MCK) promoter permitting to knock out the FNX gene leading to cardiomyopathy after 5 weeks of age [23].